EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes

Dequina A Nicholas iD, Jacques C Mbongue iD, Darysbel Garcia-Pérez, Dane Sorensen, Heather Ferguson Bennit, Marino De Leon iD, William H R Langridge

Immuno · 01.03.2024 · 4 (1) · 91-107

DOI: 10.3390/immuno4010006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immuno, online erschienen am 01.03.2024. Verfasst von Dequina A Nicholas und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of California Irvine, Irvine, CA 92697, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Around 285 million people worldwide currently have type 2 diabetes and it is projected that this number will be surpassed by 2030. Therefore, it is of the utmost importance to enhance our comprehension of the disease’s development. The regulation of diet, obesity, and inflammation in type 2 diabetes is believed to play a crucial role in enhancing insulin sensitivity and reducing the risk of onset diabetes. Obesity leads to an increase in visceral adipose tissue, which is a prominent site of inflammation in type 2 diabetes. Dyslipidemia, on the other hand, plays a significant role in attracting activated immune cells such as macrophages, dendritic cells, T cells, NK cells, and B cells to visceral adipose tissue. These immune cells are a primary source of pro-inflammatory cytokines that are believed to promote insulin resistance. This review delves into the influence of elevated dietary free saturated fatty acids and examines the cellular and molecular factors associated with insulin resistance in the initiation of inflammation induced by obesity. Furthermore, it explores novel concepts related to diet-induced inflammation and its relationship with type 2 diabetes.

Schlagwörter

Stichwörter der Autor:innen

adiposecytokinesfatty acidsimmune cellsinflammationtype 2 diabetes

Autor:innen und Institutionen

  • School of Biological Sciences, University of California Irvine, Irvine, CA 92697, USA.
  • Department of Biological Sciences, School of Arts and Sciences, Oakwood University, Huntsville, AL 35896, USA.
  • Center for Health Disparities and Molecular Medicine, School of Medicine, Loma Linda University, Loma Linda, CA 11085, USA.
  • Division of Molecular Genetics and Microbiology, School of Medicine Alumni Hall, Loma Linda University, Rm 102, 11021 Campus Street, Loma Linda, CA 92350, USA.
  • Center for Perinatal Biology, Division of Physiology, Loma Linda School of Medicine, Rm A572, 11234 Anderson Street, Loma Linda, CA 92350, USA.

ORCID-Profile: Dequina A Nicholas, Jacques C Mbongue, Marino De Leon

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Nicholas, D. A., Mbongue, J. C., Garcia-Pérez, D., Sorensen, D., Ferguson Bennit, H., De Leon, M., & Langridge, W. H. R. (2024). Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes. Immuno, 4(1), 91-107. https://doi.org/10.3390/immuno4010006

Vancouver

Nicholas DA, Mbongue JC, Garcia-Pérez D, Sorensen D, Ferguson Bennit H, De Leon M, et al. Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes. Immuno. 2024;4(1):91-107. doi:10.3390/immuno4010006

BibTeX
@article{Nicholas2024,
  author = {Nicholas, Dequina A and Mbongue, Jacques C and Garcia-Pérez, Darysbel and Sorensen, Dane and Ferguson Bennit, Heather and De Leon, Marino and Langridge, William H R},
  title = {Exploring the Interplay between Fatty Acids, Inflammation, and Type 2 Diabetes},
  journal = {Immuno},
  year = {2024},
  volume = {4},
  number = {1},
  pages = {91--107},
  doi = {10.3390/immuno4010006}
}
Kostenlos starten →